---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-007279"
form_type: "8-K"
ticker: "ODYY"
cik: "0001626644"
company_name: "Odyssey Health, Inc."
filed_at: "2022-11-04T23:59:59+00:00"
generated_at: "2026-06-22T07:01:16.339214+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Odyssey Health hires CCO and COO for NeuroPharma; salaries contingent on $5M fundraising

## Summary
- Erik Emerson named CCO and Greg Gironda named COO of Odyssey NeuroPharma, effective Nov 1, 2022.
- Each receives one-year term at 33% part-time commitment; base salary of $125K payable only after company raises $5M.
- Each granted 600K stock options: 125K vest on signing, 300K upon $5M+ financing, 175K upon Nasdaq/NYSE listing.
- Executives bring over 50 years combined pharmaceutical commercialization experience.
- Odyssey aims to advance concussion and Niemann-Pick treatments through Phase II trials.

## SEC filing metadata
- accession: 0001683168-22-007279
- form_type: 8-K
- ticker: ODYY
- cik: 0001626644
- company_name: Odyssey Health, Inc.
- filed_at: 2022-11-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626644/000168316822007279/0001683168-22-007279-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626644/000168316822007279/odyssey_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-007279
- JSON: https://secwatch.observer/filing/0001683168-22-007279.json
- Plain text: https://secwatch.observer/filing/0001683168-22-007279.txt

## Key facts
- Executive change
  Greg Gironda was appointed as Chief Operations Officer at Odyssey Health, Inc..
  - Action: appointed
  - Role: Chief Operations Officer
  source text: On November 1, 2022, the Company and Mr. Gironda entered into an employment agreement (the “Agreement”) for a one (1) year term as Chief Operations Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316822007279/0001683168-22-007279-index.htm
- Executive change
  Erik Emerson was appointed as Chief Commercial Officer at Odyssey Health, Inc..
  - Action: appointed
  - Role: Chief Commercial Officer
  source text: On November 1, 2022, the Company and Mr. Emerson entered into an employment agreement (the “Agreement”) for a one (1) year term as Chief Commercial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316822007279/0001683168-22-007279-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.